PLATINUM-SENSITIVE OVARIAN CANCER
Clinical trials for PLATINUM-SENSITIVE OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-SENSITIVE OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-SENSITIVE OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized surgery trial aims to extend remission for ovarian cancer patients
Disease control Not yet recruitingThis study aims to determine if adding a second major surgery to chemotherapy helps women with recurrent ovarian cancer live longer without their cancer worsening. It focuses on carefully selecting patients whose cancer is responding well to chemotherapy and who are most likely t…
Matched conditions: PLATINUM-SENSITIVE OVARIAN CANCER
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New Two-Pronged attack on returning ovarian cancer begins testing
Disease control Not yet recruitingThis study is testing a new combination treatment for women whose ovarian cancer has returned but still responds to platinum-based chemotherapy. It first combines a new two-in-one immunotherapy drug with standard chemotherapy, then switches to a maintenance pill called olaparib. …
Matched conditions: PLATINUM-SENSITIVE OVARIAN CANCER
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC